Who is responsible for the care of patients treated with warfarin therapy?

Lowthian, Judy A; Diug, Basia O; Evans, Sue M; Maxwell, Ellen L; Street, Alison M; Piterman, Leon; McNeil, John J

doi:10.5694/j.1326-5377.2009.tb03322.x

Topics

In reply: Bereznicki and colleagues have reinforced the importance of patient education in optimising warfarin safety, while highlighting the need for role clarification in its provision.

1 NHMRC Centre of Research Excellence in Patient Safety, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC.
2 Melbourne Pathology, Melbourne, VIC.
3 Haemostasis and Thrombosis Unit, Alfred Health, Melbourne, VIC.
4 Monash University, Melbourne, VIC.

Correspondence: Judy.Lowthian@med.monash.edu.au

1. Garcia DA, Witt DM, Hylek E, et al. Delivery of optimized anticoagulant therapy: consensus statement from the Anticoagulation Forum. Ann Pharmacother 2008; 42: 979-988.
2. Fang MC, Machtinger EL, Wang F, Schillinger D. Health literacy and anticoagulation-related outcomes among patients taking warfarin. J Gen Intern Med 2006; 21: 841-846.
3. Hutchison LC, Jones SK, West DS, Wei JY. Assessment of medication management by community-living elderly persons with two standardized assessment tools: a cross-sectional study. Am J Geriatr Pharmacother 2006; 4: 144-153.
4. Kimmel SE, Chen Z, Price M, et al. The influence of patient adherence on anticoagulation control with warfarin: results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study. Arch Intern Med 2007; 167: 229-235.
5. Newall F, Monagle P, Johnston L. Patient understanding of warfarin therapy: a review of education strategies. Hematology 2005; 10: 437-442.

Online responses are no longer available. Please refer to our instructions for authors page for more information.